Biocon Ltd
BIOCONBiocon Ltd
BIOCON
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 42.37 | 1.71 | 0.14% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.01 | 6.09 | 0.55% |
Forecast & Ratings
Detailed Forecast from 14 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Biocon Limited is a biopharmaceutical company engaged in the research & development and manufacture of pharmaceuticals, medicinal chemical and botanical products.
Investor Presentation
View olderPeers
Compare with peersHester Biosciences Ltd
Panacea Biotec Ltd
Zenotech Laboratories Ltd
Transgene Biotek Ltd
Vivo Bio Tech Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,716.70 | 4,064.50 | 4,350.90 | 5,854.30 | 6,529.40 | 7,410.20 | 8,396.70 | 11,550.10 | 15,621.20 | 15,642.40 | ||||||||||
Raw Materials | 1,330.90 | 1,515.60 | 1,677.80 | 2,106.30 | 2,190.30 | 2,533.80 | 2,975.00 | 3,817.20 | 5,754.60 | 11,574.00 | ||||||||||
| Power & Fuel Cost | 184.70 | 156.40 | 189.00 | 239.80 | 246.10 | 270.30 | 316.40 | 414.80 | 388.90 | |||||||||||
| Employee Cost | 610.10 | 747.00 | 931.10 | 1,165.30 | 1,458.80 | 1,741.00 | 1,880.10 | 2,181.00 | 2,664.10 | |||||||||||
| Selling & Administrative Expenses | 524.50 | 540.10 | 519.30 | 846.70 | 952.70 | 1,041.70 | 1,158.10 | 1,338.60 | 1,725.80 | |||||||||||
| Operating & Other expenses | 37.20 | -47.50 | -22.90 | -237.40 | -121.60 | -17.10 | 202.20 | 1,369.30 | 1,019.40 | |||||||||||
EBITDA | 1,029.30 | 1,152.90 | 1,056.60 | 1,733.60 | 1,803.10 | 1,840.50 | 1,864.90 | 2,429.20 | 4,068.40 | 4,068.40 | ||||||||||
| Depreciation/Amortization | 248.70 | 277.20 | 385.10 | 447.80 | 552.20 | 715.10 | 814.20 | 1,113.10 | 1,568.80 | 1,568.80 | ||||||||||
| PBIT | 780.60 | 875.70 | 671.50 | 1,285.80 | 1,250.90 | 1,125.40 | 1,050.70 | 1,316.10 | 2,499.60 | 2,499.60 | ||||||||||
| Interest & Other Items | 29.30 | 26.00 | 61.50 | 70.90 | 64.90 | 57.70 | 67.60 | 419.00 | 974.40 | 974.40 | ||||||||||
| PBT | 751.30 | 849.70 | 610.00 | 1,214.90 | 1,186.00 | 1,067.70 | 983.10 | 897.10 | 1,525.20 | 1,525.20 | ||||||||||
| Taxes & Other Items | 200.90 | 237.60 | 237.60 | 309.60 | 437.80 | 327.20 | 334.70 | 434.40 | 502.70 | 502.70 | ||||||||||
| Net Income | 550.40 | 612.10 | 372.40 | 905.30 | 748.20 | 740.50 | 648.40 | 462.70 | 1,022.50 | 1,022.50 | ||||||||||
| EPS | 4.59 | 5.10 | 3.10 | 7.54 | 6.23 | 6.17 | 5.40 | 3.85 | 8.52 | 8.52 | ||||||||||
| DPS | 0.83 | 0.50 | 0.50 | 0.50 | 0.00 | 0.00 | 0.50 | 1.50 | 0.50 | 1.50 | ||||||||||
| Payout ratio | 0.18 | 0.10 | 0.16 | 0.07 | 0.00 | 0.00 | 0.09 | 0.39 | 0.06 | 0.18 |
Company Updates
Peers & Comparison
Health CareBiotechnology
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Biocon Ltd | 42.37 | 1.71 | 0.14% |
| Hester Biosciences Ltd | 139.57 | 9.13 | 0.19% |
| Panacea Biotec Ltd | -558.53 | 1.00 | — |
| Zenotech Laboratories Ltd | 49.46 | 4.99 | — |
Price Comparison
Compare BIOCON with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Biocon Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
SBI FUNDS MANAGEMENT PVT LTD#SBI MF-SBI CONTRA FUND DIRECT PL GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.3592% | Percentage of the fund’s portfolio invested in the stock 1.71% | Change in the portfolio weight of the stock over the last 3 months 0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 12/110 (0) |
Kotak Equity Opportunities Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.9725% | Percentage of the fund’s portfolio invested in the stock 1.75% | Change in the portfolio weight of the stock over the last 3 months 1.75% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 45/74 (+28) |
SBI Balanced Advantage Fund - Direct Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.7840% | Percentage of the fund’s portfolio invested in the stock 1.13% | Change in the portfolio weight of the stock over the last 3 months 0.21% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 72/124 (+1) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 5, 2024
Dividend/Share
₹0.50
Ex DateEx Date
Jul 5, 2024
Cash Dividend
Ex DateEx DateJul 7, 2023
Dividend/Share
₹1.50
Ex DateEx Date
Jul 7, 2023
Cash Dividend
Ex DateEx DateJun 30, 2022
Dividend/Share
₹0.50
Ex DateEx Date
Jun 30, 2022
Cash Dividend
Ex DateEx DateJul 18, 2019
Dividend/Share
₹0.50
Ex DateEx Date
Jul 18, 2019
Cash Dividend
Ex DateEx DateJul 19, 2018
Dividend/Share
₹1.00
Ex DateEx Date
Jul 19, 2018
Biocon Ltd spurts 3.48%, gains for five straight sessions
Biocon Ltd rose for a fifth straight session today. The stock is quoting at Rs 374.45, up 3.48% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 1.28% on the day, quoting at 24718.65. The Sensex is at 80971.98, up 1.16%. Biocon Ltd has added around 8.18% in last one month. Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has added around 10% in last one month and is currently quoting at 21105.5, up 1.71% on the day. The volume in the stock stood at 66.07 lakh shares today, compared to the daily average of 47.31 lakh shares in last one month. The benchmark August futures contract for the stock is quoting at Rs 375.6, up 3.09% on the day. Biocon Ltd is up 46.21% in last one year as compared to a 25.73% gain in NIFTY and a 43.88% gain in the Nifty Pharma index.The PE of the stock is 411.02 based on TTM earnings ending March 24.Powered by Capital Market - Live
Syngene Q1 Results: Net profit drops 19% to Rs 76 crore
Union Budget has positive indicators on economic growth and development: Kiran Mazumdar Shaw
Budget 2024: Biocon’s Kiran Mazumdar-Shaw Positive On Budget, Stresses GST Rationalisation
Budget 2024: These sectors are the potential winners and losers of Modi 3.0 budget
Biocon will hold a meeting of the Board of Directors of the Company on 8 August 2024.Powered by Capital Market - Live
Karnataka Industries Minister jumps to douse fire as top industrialists slam bill for jobs for locals
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 21.69%, vs industry avg of 19.21%
Increasing Market Share
Over the last 5 years, market share increased from 84.66% to 93.82%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 2.46%, vs industry avg of 1.49%